125 related articles for article (PubMed ID: 24471491)
1. Polycystic ovary syndrome and low-grade inflammation with special reference to YKL-40.
Aziz M; Wissing ML; Naver KV; Faber J; Skouby SO
Gynecol Endocrinol; 2014 Apr; 30(4):311-5. PubMed ID: 24471491
[TBL] [Abstract][Full Text] [Related]
2. Elevated circulating levels of YKL-40 are a marker of abnormal glucose tolerance in women with polycystic ovary syndrome.
Celik C; Abali R; Guzel S; Bastu E; Kucukyalcin V; Yilmaz M
Clin Endocrinol (Oxf); 2012 Dec; 77(6):893-7. PubMed ID: 22583189
[TBL] [Abstract][Full Text] [Related]
3. Endogenous thrombin potential in polycystic ovary syndrome: the association to body mass index, insulin resistance, and inflammation.
Aziz M; Sidelmann JJ; Wissing ML; Faber J; Skouby SO
Gynecol Endocrinol; 2015; 31(9):720-4. PubMed ID: 26291802
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes.
Aziz M; Sidelmann JJ; Faber J; Wissing ML; Naver KV; Mikkelsen AL; Nilas L; Skouby SO
Acta Obstet Gynecol Scand; 2015 Oct; 94(10):1082-9. PubMed ID: 26123797
[TBL] [Abstract][Full Text] [Related]
5. Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children.
Kyrgios I; Galli-Tsinopoulou A; Stylianou C; Papakonstantinou E; Arvanitidou M; Haidich AB
Metabolism; 2012 Apr; 61(4):562-8. PubMed ID: 22036069
[TBL] [Abstract][Full Text] [Related]
6. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
7. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
8. Obesity and inflammatory biomarkers in women with polycystic ovary syndrome.
Shen SH; Shen SY; Liou TH; Hsu MI; Chang YC; Cheng CY; Hsu CS; Tzeng CR
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():66-71. PubMed ID: 26177495
[TBL] [Abstract][Full Text] [Related]
9. Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome.
Moradi S; Mollabashi M; Kerman SR
Gynecol Endocrinol; 2011 Jul; 27(7):480-5. PubMed ID: 20836727
[TBL] [Abstract][Full Text] [Related]
10. Relationship among plasma adipokines, insulin and androgens level as well as biochemical glycemic and lipidemic markers with incidence of PCOS in women with normal BMI.
Akbarzadeh S; Ghasemi S; Kalantarhormozi M; Nabipour I; Abbasi F; Aminfar A; Jaffari SM; Motamed N; Movahed A; Mirzaei M; Rahbar AR
Gynecol Endocrinol; 2012 Jul; 28(7):521-4. PubMed ID: 22309615
[TBL] [Abstract][Full Text] [Related]
11. The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome.
Souza Dos Santos AC; Soares NP; Costa EC; de Sá JC; Azevedo GD; Lemos TM
Gynecol Endocrinol; 2015 Mar; 31(3):225-8. PubMed ID: 25373529
[TBL] [Abstract][Full Text] [Related]
12. Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome.
Wu Y; Zhang J; Wen Y; Wang H; Zhang M; Cianflone K
Fertil Steril; 2009 Jan; 91(1):213-9. PubMed ID: 18206145
[TBL] [Abstract][Full Text] [Related]
13. Vigorous exercise is associated with superior metabolic profiles in polycystic ovary syndrome independent of total exercise expenditure.
Greenwood EA; Noel MW; Kao CN; Shinkai K; Pasch LA; Cedars MI; Huddleston HG
Fertil Steril; 2016 Feb; 105(2):486-93. PubMed ID: 26551442
[TBL] [Abstract][Full Text] [Related]
14. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
15. Associations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 Diabetes.
Thomsen SB; Gjesing AP; Rathcke CN; Ekstrøm CT; Eiberg H; Hansen T; Pedersen O; Vestergaard H
PLoS One; 2015; 10(7):e0133672. PubMed ID: 26197239
[TBL] [Abstract][Full Text] [Related]
16. Association between red blood cell distribution width and polycystic ovary syndrome.
Yilmaz Ö; Mehmet C; Kelekci S; Temur M
Endocr Res; 2015; 40(4):181-7. PubMed ID: 25531764
[TBL] [Abstract][Full Text] [Related]
17. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M
Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198
[TBL] [Abstract][Full Text] [Related]
18. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.
Aydogdu A; Tasci I; Tapan S; Basaran Y; Aydogan U; Meric C; Sonmez A; Aydogdu S; Akbulut H; Taslipinar A; Uckaya G; Azal O
Gynecol Endocrinol; 2012 Sep; 28(9):722-5. PubMed ID: 22304663
[TBL] [Abstract][Full Text] [Related]
19. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome.
Olszanecka-Glinianowicz M; Madej P; Owczarek A; Chudek J; Skałba P
Clin Endocrinol (Oxf); 2015 Jul; 83(1):98-104. PubMed ID: 25440474
[TBL] [Abstract][Full Text] [Related]
20. Assessing C reactive protein/albumin ratio as a new biomarker for polycystic ovary syndrome: a case-control study of women from Bahraini medical clinics.
Kalyan S; Goshtesabi A; Sarray S; Joannou A; Almawi WY
BMJ Open; 2018 Oct; 8(10):e021860. PubMed ID: 30368447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
